MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

vTv Therapeutics Company Profile (NASDAQ:VTVT)

Consensus Ratings for vTv Therapeutics (NASDAQ:VTVT) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $19.25 (235.37% upside)

Analysts' Ratings History for vTv Therapeutics (NASDAQ:VTVT)
Show:
DateFirmActionRatingPrice TargetActions
12/17/2015Janney Montgomery ScottInitiated CoverageBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2015Canaccord GenuityInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/24/2015Piper JaffrayInitiated CoverageOverweight$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/24/2015Stifel NicolausInitiated CoverageBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha